(2R)-2-(2-hydroxypropan-2-yl)-5-methyl-3,4-dihydro-2H-oxepin-7-one

Details

Top
Internal ID 0b3c3758-865e-4e40-8ea6-f4db3ad9a9b5
Taxonomy Organic oxygen compounds > Organooxygen compounds > Alcohols and polyols > Tertiary alcohols
IUPAC Name (2R)-2-(2-hydroxypropan-2-yl)-5-methyl-3,4-dihydro-2H-oxepin-7-one
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C10H16O3/c1-7-4-5-8(10(2,3)12)13-9(11)6-7/h6,8,12H,4-5H2,1-3H3/t8-/m1/s1
InChI Key ICSVRXLISHBJRU-MRVPVSSYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H16O3
Molecular Weight 184.23 g/mol
Exact Mass 184.109944368 g/mol
Topological Polar Surface Area (TPSA) 46.50 Ų
XlogP 1.00
Atomic LogP (AlogP) 1.41
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R)-2-(2-hydroxypropan-2-yl)-5-methyl-3,4-dihydro-2H-oxepin-7-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9742 97.42%
Caco-2 + 0.8034 80.34%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability + 0.5857 58.57%
Subcellular localzation Mitochondria 0.6668 66.68%
OATP2B1 inhibitior - 0.8441 84.41%
OATP1B1 inhibitior + 0.9307 93.07%
OATP1B3 inhibitior + 0.9531 95.31%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior - 0.9576 95.76%
P-glycoprotein inhibitior - 0.9656 96.56%
P-glycoprotein substrate - 0.9435 94.35%
CYP3A4 substrate - 0.5502 55.02%
CYP2C9 substrate + 0.5918 59.18%
CYP2D6 substrate - 0.9078 90.78%
CYP3A4 inhibition - 0.9165 91.65%
CYP2C9 inhibition - 0.7243 72.43%
CYP2C19 inhibition - 0.7190 71.90%
CYP2D6 inhibition - 0.9112 91.12%
CYP1A2 inhibition - 0.6527 65.27%
CYP2C8 inhibition - 0.9447 94.47%
CYP inhibitory promiscuity - 0.9449 94.49%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.8643 86.43%
Carcinogenicity (trinary) Non-required 0.5590 55.90%
Eye corrosion - 0.9416 94.16%
Eye irritation - 0.5309 53.09%
Skin irritation + 0.5909 59.09%
Skin corrosion - 0.8524 85.24%
Ames mutagenesis - 0.7900 79.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7589 75.89%
Micronuclear - 0.9000 90.00%
Hepatotoxicity + 0.7388 73.88%
skin sensitisation + 0.5772 57.72%
Respiratory toxicity - 0.5667 56.67%
Reproductive toxicity - 0.5275 52.75%
Mitochondrial toxicity - 0.6375 63.75%
Nephrotoxicity - 0.6961 69.61%
Acute Oral Toxicity (c) III 0.6006 60.06%
Estrogen receptor binding - 0.8031 80.31%
Androgen receptor binding - 0.7426 74.26%
Thyroid receptor binding - 0.8593 85.93%
Glucocorticoid receptor binding - 0.8164 81.64%
Aromatase binding - 0.9204 92.04%
PPAR gamma - 0.6153 61.53%
Honey bee toxicity - 0.9611 96.11%
Biodegradation - 0.5250 52.50%
Crustacea aquatic toxicity - 0.5000 50.00%
Fish aquatic toxicity + 0.7542 75.42%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.25% 97.25%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.82% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.76% 91.11%
CHEMBL230 P35354 Cyclooxygenase-2 92.17% 89.63%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 87.47% 99.23%
CHEMBL5966 P55899 IgG receptor FcRn large subunit p51 87.31% 90.93%
CHEMBL2581 P07339 Cathepsin D 87.09% 98.95%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.05% 97.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 84.97% 89.00%
CHEMBL1871 P10275 Androgen Receptor 84.12% 96.43%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.06% 100.00%
CHEMBL3401 O75469 Pregnane X receptor 83.08% 94.73%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 82.14% 93.04%

Cross-Links

Top
PubChem 76319759
NPASS NPC310210
LOTUS LTS0113113
wikiData Q105111145